U.S. flag

An official website of the United States government

NM_000396.4(CTSK):c.934C>T (p.Arg312Ter) AND Pyknodysostosis

Germline classification:
Pathogenic/Likely pathogenic (4 submissions)
Last evaluated:
Mar 24, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000410122.5

Allele description [Variation Report for NM_000396.4(CTSK):c.934C>T (p.Arg312Ter)]

NM_000396.4(CTSK):c.934C>T (p.Arg312Ter)

Gene:
CTSK:cathepsin K [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1q21.3
Genomic location:
Preferred name:
NM_000396.4(CTSK):c.934C>T (p.Arg312Ter)
HGVS:
  • NC_000001.11:g.150796855G>A
  • NG_011848.1:g.16482C>T
  • NM_000396.4:c.934C>TMANE SELECT
  • NP_000387.1:p.Arg312Ter
  • NC_000001.10:g.150769331G>A
  • NM_000396.3:c.934C>T
Protein change:
R312*
Links:
dbSNP: rs375958814
NCBI 1000 Genomes Browser:
rs375958814
Molecular consequence:
  • NM_000396.4:c.934C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Pyknodysostosis
Synonyms:
Pycnodysostosis
Identifiers:
MONDO: MONDO:0009940; MedGen: C0238402; Orphanet: 763; OMIM: 265800

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000487003Counsyl
criteria provided, single submitter

(Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015))
Likely pathogenic
(Sep 22, 2016)
unknownclinical testing

PubMed (2)
[See all records that cite these PMIDs]

mdi-5618_320494_Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015).pdf,

Citation Link,

SCV002811002Fulgent Genetics, Fulgent Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Apr 13, 2022)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004049710Genome-Nilou Lab
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Apr 11, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV005058616Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Mar 24, 2024)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenonot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutations of the C-terminal end of cathepsin K affect proenzyme secretion and intracellular maturation.

Claveau D, Riendeau D.

Biochem Biophys Res Commun. 2001 Feb 23;281(2):551-7.

PubMed [citation]
PMID:
11181082

Cathepsin K analysis in a pycnodysostosis cohort: demographic, genotypic and phenotypic features.

Arman A, Bereket A, Coker A, Kiper PÖ, Güran T, Ozkan B, Atay Z, Akçay T, Haliloglu B, Boduroglu K, Alanay Y, Turan S.

Orphanet J Rare Dis. 2014 Apr 26;9:60. doi: 10.1186/1750-1172-9-60.

PubMed [citation]
PMID:
24767306
PMCID:
PMC4022088
See all PubMed Citations (3)

Details of each submission

From Counsyl, SCV000487003.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Fulgent Genetics, Fulgent Genetics, SCV002811002.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Genome-Nilou Lab, SCV004049710.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV005058616.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024